The Pan American Health Organization (PAHO) has launched the “Better with PrEP” campaign, with the goal of expanding access ...

The Pan American Health Organisation has launched the "Better with PrEP" campaign, with the goal of expanding access to ...

Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.

Health experts say lenacapavir could reduce the number of global HIV infections significantly. It can protect against HIV ...

Ahead of World AIDS Day, Unitaid is announcing a US$22 million investment to accelerate the introduction and access to ...

Each life lost to AIDS is a life too many . As donor funds dry up, Africa needs new ways to fight this epidemic .

Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...

By Joseph Erunke, Abuja The World Health Organization, WHO, says about 21.3 million people are currently on antiretroviral ...

The president and First Lady Jill Biden will host a public display of the Quilt for the first time on the South Lawn that ...

Campaigns on HIV awareness also stress preventive measures, such as the use of condoms, regular testing, and the role of ...